iRhythm Holdings Inc. (IRTC)
NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 104.99 0.00%
IRTC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.46B
- Forward P/E
- 81.92
- EPS (TTM)
- -$0.42
- Dividend yield
- None
- 52-week range
- 100.85 – 212.00
- Day range
- 104.70 – 108.01
- Volume / Avg
- 450.29K / 574.60K
- Beta
- —
- Shares outstanding
- 32.96M
- Next earnings
- Oct 29, 2026
52-week range
IRTC stock today
iRhythm (IRTC) closed at $104.99 on Oct 7, down 2.06% (-$2.21), versus the S&P 500's 0.22% decline. At this level, IRTC sits near the bottom of its 52-week range of $100.85 to $212.00: 50.5% below the high, set on Oct 31, 2025 and 4.1% above the low. IRTC is down 40.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 40.8%.
iRhythm has posted a net loss over the last twelve months (EPS of -$0.42), so its P/E ratio is not meaningful. iRhythm's next earnings report is expected on Oct 29, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About iRhythm
Company profileiRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Quentin S. Blackford
- Headquarters
- San Francisco, CA
- Employees
- 2,400
- IPO year
- 2016
- Website
- irhythmtech.com
Analyst forecast
ForecastConsensus (15 analysts)
strong_buy
Avg. price target
$173.93+65.66%
- Strong buy 2
- Buy 13
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 29, 2026
- EPS estimate
- $0.02
iRhythm peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PLSEPulse Biosciences Inc | 49.09 | -1.33% | $3.50B | vs IRTC |
| NVSTEnvista Holdings Corporation | 23.04 | -0.99% | $3.70B | vs IRTC |
| ICUIICU Medical Inc. | 156.03 | -2.32% | $3.90B | vs IRTC |
| HTFLHeartflow Inc. | 49.36 | -2.62% | $4.29B | vs IRTC |
| ATRCAtriCure Inc. | 53.31 | -0.69% | $2.71B | vs IRTC |
| HAEHaemonetics Corporation | 101.71 | -1.75% | $4.63B | vs IRTC |
| UFPTUFP Technologies Inc. | 292.87 | -3.30% | $2.27B | vs IRTC |
| MMSIMerit Medical Systems Inc. | 85.09 | +0.15% | $5.08B | vs IRTC |
Indexes, lists and sector
iRhythm stock FAQ
What is iRhythm's stock price today?
IRTC last traded at $104.99 as of Oct 7, 4:00 PM EDT, down 2.06% on the day. Prices are delayed at least 15 minutes.
When is iRhythm's next earnings date?
iRhythm is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $0.02.
Who is iRhythm's CEO?
Mr. Quentin S. Blackford is the chief executive officer of iRhythm Holdings Inc., which has about 2,400 employees.
What is the IRTC 52-week high?
The 52-week high for IRTC is $212.00 and the 52-week low is $100.85. The stock is currently 50.5% below its high.